Endothelial damage inhibitors for improvement of saphenous vein graft patency in coronary artery bypass grafting
{{output}}
The saphenous vein graft (SVG) remains the most commonly used conduit in coronary artery bypass grafting (CABG). In light of this further research must be aimed at the development of strategies to optimize SVG patency and thereby improve both short- and long-t... ...
